Rezultati - Schoeberl, Birgit

An expanding role for cell biologists in drug discovery and pharmacology od Sorger, Peter K., Schoeberl, Birgit

Polni tekst Polni tekst Polni tekst

Competing Docking Interactions can Bring About Bistability in the MAPK Cascade od Legewie, Stefan, Schoeberl, Birgit, Blüthgen, Nils, Herzel, Hanspeter

Polni tekst Polni tekst Polni tekst

Tensor clustering with algebraic constraints gives interpretable groups of crosstalk mechanisms in breast cancer od Seigal, Anna, Beguerisse-Díaz, Mariano, Schoeberl, Birgit, Niepel, Mario, Harrington, Heather A.

Polni tekst Polni tekst Polni tekst

Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles od Kanodia, Jitendra, Chai, Diana, Vollmer, Jannik, Kim, Jaeyeon, Raue, Andreas, Finn, Greg, Schoeberl, Birgit

Polni tekst Polni tekst Polni tekst

Autocrine signaling is a key regulatory element during osteoclastogenesis od Kopesky, Paul, Tiedemann, Kerstin, Alkekhia, Dahlia, Zechner, Christoph, Millard, Bjorn, Schoeberl, Birgit, Komarova, Svetlana V.

Polni tekst Polni tekst Polni tekst

Effects of Insulin-like Growth Factor-1 and Dexamethasone on Cytokine-Challenged Cartilage: Relevance to Post Traumatic Osteoarthritis od Li, Yang, Wang, Yang, Chubinskaya, Susanna, Schoeberl, Birgit, Florine, Emily, Kopesky, Paul, Grodzinsky, Alan J.

Polni tekst Polni tekst Polni tekst

Estimation of immune cell content in tumour tissue using single-cell RNA-seq data od Schelker, Max, Feau, Sonia, Du, Jinyan, Ranu, Nav, Klipp, Edda, MacBeath, Gavin, Schoeberl, Birgit, Raue, Andreas

Polni tekst Polni tekst Polni tekst

Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data od Chen, William W, Schoeberl, Birgit, Jasper, Paul J, Niepel, Mario, Nielsen, Ulrik B, Lauffenburger, Douglas A, Sorger, Peter K

Polni tekst Polni tekst Polni tekst

Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines od Niepel, Mario, Hafner, Marc, Pace, Emily A., Chung, Mirra, Chai, Diana H., Zhou, Lili, Schoeberl, Birgit, Sorger, Peter K.

Polni tekst Polni tekst Polni tekst

HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B od Kirouac, Daniel C., Du, Jinyan, Lahdenranta, Johanna, Onsum, Matthew D., Nielsen, Ulrik B., Schoeberl, Birgit, McDonagh, Charlotte F.

Polni tekst Polni tekst Polni tekst

Navigating Between Right, Wrong, and Relevant: The Use of Mathematical Modeling in Preclinical Decision Making od Kondic, Anna, Bottino, Dean, Harrold, John, Kearns, Jeffrey D., Musante, CJ, Odinecs, Aleksandrs, Ramanujan, Saroja, Selimkhanov, Jangir, Schoeberl, Birgit

Polni tekst Polni tekst Polni tekst

Analysis of growth factor signaling in genetically diverse breast cancer lines od Niepel, Mario, Hafner, Marc, Pace, Emily A, Chung, Mirra, Chai, Diana H, Zhou, Lili, Muhlich, Jeremy L, Schoeberl, Birgit, Sorger, Peter K

Polni tekst Polni tekst Polni tekst

Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies od Zhou, Yu, Goenaga, Anne-Laure, Harms, Brian D., Zou, Hao, Lou, Jianlong, Conrad, Fraser, Adams, Gregory P., Schoeberl, Birgit, Nielsen, Ulrik B., Marks, James D.

Polni tekst Polni tekst Polni tekst

Predicting ligand-dependent tumors from multi-dimensional signaling features od Hass, Helge, Masson, Kristina, Wohlgemuth, Sibylle, Paragas, Violette, Allen, John E., Sevecka, Mark, Pace, Emily, Timmer, Jens, Stelling, Joerg, MacBeath, Gavin, Schoeberl, Birgit, Raue, Andreas

Polni tekst Polni tekst Polni tekst

Rapid optimization and prototyping for therapeutic antibody-like molecules od Xu, Lihui, Kohli, Neeraj, Rennard, Rachel, Jiao, Yang, Razlog, Maja, Zhang, Kathy, Baum, Jason, Johnson, Bryan, Tang, Jian, Schoeberl, Birgit, Fitzgerald, Jonathan, Nielsen, Ulrik, Lugovskoy, Alexey A.

Polni tekst Polni tekst Polni tekst

Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer od Camblin, Adam J., Tan, Gege, Curley, Michael D., Yannatos, Isabel, Iadevaia, Sergio, Rimkunas, Victoria, Mino-Kenudson, Mari, Bloom, Troy, Schoeberl, Birgit, Drummond, Daryl C., Lugovskoy, Alexey A., Louis, Chrystal U., Askoxylakis, Vasileios

Polni tekst Polni tekst Polni tekst

Ten simple rules to power drug discovery with data science od Ferrero, Enrico, Brachat, Sophie, Jenkins, Jeremy L., Marc, Philippe, Skewes-Cox, Peter, Altshuler, Robert C., Gubser Keller, Caroline, Kauffmann, Audrey, Sassaman, Erik K., Laramie, Jason M., Schoeberl, Birgit, Borowsky, Mark L., Stiefl, Nikolaus

Polni tekst Polni tekst Polni tekst

An ErbB3 antibody, MM-121, is active in cancers with ligand dependent activation od Schoeberl, Birgit, Faber, Anthony C., Li, Danan, Liang, Mei-Chih, Crosby, Katherine, Onsum, Matthew, Burenkova, Olga, Pace, Emily, Walton, Zandra, Nie, Lin, Fulgham, Aaron, Song, Youngchul, Nielsen, Ulrik B., Engelman, Jeffrey A., Wong, Kwok-Kin

Polni tekst Polni tekst Polni tekst

An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells od Sheng, Qing, Liu, Xinggang, Fleming, Eleanor, Yuan, Karen, Piao, Huiying, Chen, Jinyun, Moustafa, Zeinab, Thomas, Roman K., Greulich, Heidi, Schinzel, Anna, Zaghlul, Sara, Batt, David, Ettenberg, Seth, Meyerson, Matthew, Schoeberl, Birgit, Kung, Andrew L., Hahn, William C., Drapkin, Ronny, Livingston, David M., Liu, Joyce F.

Polni tekst Polni tekst Polni tekst

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM od Casaletto, Jessica B., Geddie, Melissa L., Abu-Yousif, Adnan O., Masson, Kristina, Fulgham, Aaron, Boudot, Antoine, Maiwald, Tim, Kearns, Jeffrey D., Kohli, Neeraj, Su, Stephen, Razlog, Maja, Raue, Andreas, Kalra, Ashish, Håkansson, Maria, Logan, Derek T., Welin, Martin, Chattopadhyay, Shrikanta, Harms, Brian D., Nielsen, Ulrik B., Schoeberl, Birgit, Lugovskoy, Alexey A., MacBeath, Gavin

Polni tekst Polni tekst Polni tekst